Insulet (PODD) Divestments (2016)
Insulet (PODD) posted Divestments of $1.1 million for Q2 2016, down 76.16% on a QoQ basis from $4.6 million in Q1 2016.
Insulet (PODD) Divestments (2016) Analysis & Trends
Insulet's Divestments history runs 1 years deep, the most recent figure standing at $1.1 million for Q2 2016.
- Quarterly Divestments changed N/A year-over-year to $1.1 million in Q2 2016, while the trailing twelve-month figure through Mar 2017 was $1.1 million (down 76.16% YoY) and the FY2016 annual result came in at $5.7 million, changed N/A from the prior year.
- Divestments was $1.1 million for Q2 2016 at Insulet, down from $4.6 million in the prior quarter.
- Across five years, Divestments topped out at $4.6 million in Q1 2016 and bottomed at $1.1 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.17 Bn | 175.87 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.06 Bn | 126.18 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.08 Bn | 25.80 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 9.37 Mn |
| 10 | Insulet | 11.62 Bn | 11.14 Bn | 529.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 1.10 Mn |
| Mar 31, 2016 | 4.61 Mn |